Skip to main content
SpringerLink
Log in

Treatment of Parkinsonism

  • Chapter
  • First Online:
Parkinson’s Disease

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 90))

Abstract

Over the last decade the treatment of Parkinsonism has under gone major developments. Advances deriving from a logically structured series of laboratory experiments have been transferred to the clinic to generate substantial therapeutic achievements.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Cools, A.R. and Van Rossum, J.M. (1975). Excitation-mediating and inhibition-mediating dopamine-receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data. Psychopharma- cologia (Berl). 45 ,243–254.

    Article  Google Scholar 

  • Cotzias, G.C., Lawrence, W.H., Papavasiliou, P.S., Tolosa, E.S., Mendez, J.S. and Bell-Medura, M. (1976). Treatment of Park inson’s disease with aporphines, possible role of growth hormone. New Engl J. Med 294 ,567–572.

    Article  CAS  PubMed  Google Scholar 

  • Creese, I.N., Bunt, D.R. and Snyder, S.H. (1976). Dopamine receptor binding; differentiation of agonist and antagonist states with 3H-holaperidol. Life Sci. 17 ,993–1002.

    Article  Google Scholar 

  • Greenacre, J.K., Coxon, A., Petrie, A. and Reid, J.L. (1976). Comparison of levodopa with carbidopa or benserazide in parkin-sonism. Lancet 2 ,381–384.

    Article  CAS  PubMed  Google Scholar 

  • Jaton, A.L., Loew, D.M. and Vigouret, J.M. (1975). CF 25–397 (9,10 didehydro-6-methyl-8Ăź-[2-pyridylthiomethyl] ergoline), anew central dopamine receptor agonist. Proc B.P.S. 56 ,371.

    Google Scholar 

  • Kartzinel, R. and Calne, D.B. (1976). Studies with bromocriptine Part I. “On-off” phenomena. Neurology, 26 ,508–510.

    Article  Google Scholar 

  • Kartzinel, R., Perlow, M.J., Carter, A.C., Chase, T.N. and Calne, D.B. (1976). Metabolic studies with bromocriptine in patients with idiopathic Parkinsonism and Huntington’s Chorea. Trans Am Neurol Assoc. In press.

    Google Scholar 

  • Kartzinel, R., Perlow, M., Teychenne, P., Gielen, A., Gillespie, M., Sadowsky, D. and Calne, D.B. (1976). Bromocriptine and levodopa (with or without carbidopa) in Parkinsonism. Lancet 2 ,272–275.

    Article  CAS  PubMed  Google Scholar 

  • Libet, B. and Tosaka, T. (1970). Dopamine as a synaptic transmitter and modulator in sympathetic ganglia: A different mode of synaptic action. Proc Nat Acad Sci USA 67 ,667–673.

    Article  CAS  PubMed  Google Scholar 

  • Lieberman, A., Miyamoto, T., Battista, A. and Goldstein, M. (1975). Studies on the anti-Parkinsonian efficacy of lergotrile. Neurol. 25 ,459–462.

    Article  CAS  Google Scholar 

  • Lloyd, K.G., Davidson, L. and Hornykiewicz, O. (1973). Metabolism of levodopa in the human brain. In Advances in Neurology, Vol. 3, (Calne, D.B., Ed.) pp. 173–188. Raven Press, New York.

    Google Scholar 

  • Marsden, CD. and Parkes, J.D. (1976). “On-off” effects in patients with Parkinson’s disease on chronic levodopa therapy. Lancet 1 ,292–296.

    Article  CAS  PubMed  Google Scholar 

  • McLennan, H. and York, D.H. (1967). The action of dopamine on neurons of the caudate nucleus. J. Physiol. (Lond). 189 ,393–402.

    Article  CAS  PubMed Central  Google Scholar 

  • Reid, J.L., Calne, D.B., Vakil, S.D., Allen, J.C. and Davies, C.A. (1972). Plasma concentrations of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase. J. Neurol Sci. 17 ,45–51.

    Article  CAS  PubMed  Google Scholar 

  • Silbergeld, E.K., Adler, H., Kennedy, S. and Calne, D.B. (1976).Roles of presynaptic dopamine function and hepatic drug metabolism in effects of three dopamine agonists: bromocriptine, lergotrile and CF25-397. In press.

    Google Scholar 

  • Silbergeld, E.K. and Pfeiffer, R.F. (1976). Differential effects of three dopamine agonists: apomorphine, bromocriptine and lergotrile. In press.

    Google Scholar 

  • Teychenne, P.F., Jones, A. and Calne, D.B. (1976). Changes in liver function induced by lergotrile. In preparation.

    Google Scholar 

  • Teychenne, P.F., Pfeiffer, R.F. and Calne, D.B. (1976). Actions of CF25–397 in parkinsonism. In preparation.

    Google Scholar 

  • Yahr, M.D. (ed.) (1973). In Advances in Neurology, Vol. 2-Treatment of Parkinson’s Disease-the Use of Dopa Deoarboxylase Inhibitors. pp. 303. Raven Press, New York.

    Google Scholar 

  • Yahr, M.D. (1975). Levodopa. Ann Intern Med. 83 ,667–682.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Experimental Therapeutics Branch, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, Maryland, 20014, USA

    D. B. Calne, P. F. Teychenne & R. F. Pfeiffer

  2. Department of Health, Education and Welfare, National Institutes of Health, Bethesda, Maryland, 20014, USA

    D. B. Calne, P. F. Teychenne & R. F. Pfeiffer

Authors
  1. D. B. Calne
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. F. Teychenne
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. F. Pfeiffer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Pharmacology and Therapeutics and Psychiatry, Texas Tech University School of Medicine, Lubbock, Texas, USA

    Fathy S. Messiha Ph. D. (Associate Professor, Chairman) (Associate Professor, Chairman)

  2. Department of Pharmacology and Therapeutics, Tarbox Parkinson’s Disease Institute, Texas Tech University School of Medicine, Lubbock, Texas, USA

    Alexander D. Kenny Ph. D. (Professor and Chairman, Acting Director) (Professor and Chairman, Acting Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1977 Plenum Press, New York

About this chapter

Cite this chapter

Calne, D.B., Teychenne, P.F., Pfeiffer, R.F. (1977). Treatment of Parkinsonism. In: Messiha, F.S., Kenny, A.D. (eds) Parkinson’s Disease. Advances in Experimental Medicine and Biology, vol 90. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-2511-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-2511-6_3

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4684-2513-0

  • Online ISBN: 978-1-4684-2511-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation